Cumberland Pharmaceuticals (CPIX) Interest Expenses (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Interest Expenses data on file, last reported at $85839.0 in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 47.6% year-over-year to $85839.0; the trailing twelve-month figure through Mar 2026 stood at $585844.0 (down 19.15% YoY), and the FY2025 full-year result was $495990.0, down 18.09% from the prior year.
• Interest Expenses eased to $85839.0 in Q1 2026, from $112942.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $8.7 million in Q2 2024 to a low of $85839.0 in Q1 2026.
• A 5-year average of $1.9 million and a median of $608015.0 in 2023 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses jumped 2939.94% in 2022 and tumbled 95.12% in 2025, its largest moves.
• Tracing CPIX's Interest Expenses over 5 years: stood at $179456.0 in 2022, then slipped by 11.92% to $158068.0 in 2023, then soared by 41.24% to $223261.0 in 2024, then tumbled by 49.41% to $112942.0 in 2025, then dropped by 24.0% to $85839.0 in 2026.
• Business Quant data shows CPIX's Interest Expenses at $85839.0 in Q1 2026, $112942.0 in Q4 2025, and $2.6 million in Q3 2025.